JPH0231954B2 - KOSONOANTEIKAZAIOYOBIKOSOHOZONHOHO - Google Patents
KOSONOANTEIKAZAIOYOBIKOSOHOZONHOHOInfo
- Publication number
- JPH0231954B2 JPH0231954B2 JP13650084A JP13650084A JPH0231954B2 JP H0231954 B2 JPH0231954 B2 JP H0231954B2 JP 13650084 A JP13650084 A JP 13650084A JP 13650084 A JP13650084 A JP 13650084A JP H0231954 B2 JPH0231954 B2 JP H0231954B2
- Authority
- JP
- Japan
- Prior art keywords
- enzyme
- sucrose
- lactose
- inositol
- catalase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000004190 Enzymes Human genes 0.000 claims description 45
- 108090000790 Enzymes Proteins 0.000 claims description 45
- 229930006000 Sucrose Natural products 0.000 claims description 28
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 28
- 239000005720 sucrose Substances 0.000 claims description 28
- 239000003381 stabilizer Substances 0.000 claims description 20
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 17
- 239000008101 lactose Substances 0.000 claims description 17
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 15
- 102000016938 Catalase Human genes 0.000 claims description 14
- 108010053835 Catalase Proteins 0.000 claims description 14
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 14
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 14
- 229960000367 inositol Drugs 0.000 claims description 14
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 14
- 108010025188 Alcohol oxidase Proteins 0.000 claims description 13
- 238000004108 freeze drying Methods 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 6
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 5
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 claims description 5
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 5
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 5
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 5
- 239000004473 Threonine Substances 0.000 claims description 5
- 229960001230 asparagine Drugs 0.000 claims description 5
- 235000009582 asparagine Nutrition 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 238000004321 preservation Methods 0.000 claims description 2
- 229940088598 enzyme Drugs 0.000 description 38
- 229960004793 sucrose Drugs 0.000 description 24
- 230000000694 effects Effects 0.000 description 15
- 229960001375 lactose Drugs 0.000 description 7
- 241001149698 Lipomyces Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000009849 deactivation Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 108010024957 Ascorbate Oxidase Proteins 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 108010089254 Cholesterol oxidase Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010059881 Lactase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 108010090622 glycerol oxidase Proteins 0.000 description 1
- 239000003262 industrial enzyme Substances 0.000 description 1
- 229940116108 lactase Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
Description
〔発明の目的〕
本発明は酵素の安定化剤及び酵素保存方法に関
するものである。さらに詳しくは、酵素活性の低
下を防止し、長期にわたつて酵素活性を維持する
ために添加される酵素の安定化剤及びこれによつ
て安定化された酵素保存方法に関するものであ
る。その目的とするところは不安定な酵素を長期
間にわたつて安定に保ち有効に利用できるように
することにある。
〔産業上の利用分野〕
酵素含有組成物は、酵素試薬、臨床分析用酵
素、食品用工業用酵素など触媒として数多くの分
野で使用されている。しかしながらこれら酵素含
有組成物は、保存中での失活、凍結乾燥時での失
活が起こることがあり、酵素を安定化し、その失
活を防ぐことが酵素を利用する産業分野において
必要である。
〔従来の技術〕
従来、酵素組成物の安定化剤としては、牛血清
アルグミン、人血清アルグミン、卵白アルグミン
などの酵素活性のない蛋白質、シヨ糖、グルコー
ス、乳糖、水溶性多類糖などの糖類、硫安などの
塩類及びグリセロール、有機溶媒などが用いられ
てきた。
〔発明が解決しようとする問題点〕
前記したような酵素安定化剤を単独で使用して
も酵素によつては満足な安定化効果が得られな
い、即ち、凍結乾燥保存後数ケ月を経て酵素活性
が低下している場合があつた。特にアルコールオ
キシダーゼ及びカタラーゼに関しては、凍結乾燥
時及びその後の安定性試験で顕著な酵素活性低下
が起こるという問題があつた。この二種の酵素の
活性を出来る限り安定に保つことのできる安定化
剤について研究を行ない本発明に至つた。
〔問題を解決するための手段〕
そこで本発明者らは、この二種の酵素の活性を
出来る限り凍結乾燥後も安定に保つことのでる安
定化剤について鋭意研究の結果、従来知られてい
る酵素安定化剤の特定の組合せのものが従来の安
定剤を単独使用した場合に比べ飛躍的に安定性を
向上させることを見出し本発明を完成するに至つ
た。
即ち、本発明はシヨ糖(A)と乳糖、イノシトー
ル、ソルボース、アスパラギン、トレオニンより
なる群から選択される化合物(B)との2種類以上を
含んでなる酵素の安定化剤及びこの安定化剤と酵
素とからなる組成物を凍結乾燥してなる酵素保存
方法を提供するものである。
本発明の酵素の安定化剤は、シヨ糖と乳糖、シ
ヨ糖と乳糖とイノシトール、シヨ糖とトレオニ
ン、シヨ糖とソルボース、シヨ糖とアスパラギ
ン、シヨ糖とイノシトールの組合せが好ましく、
特にシヨ糖と乳糖、シヨ糖と乳糖とイノシトール
の組合せが好ましい。
これらのシヨ糖(A)と選択される化合物(B)の混合
割合は、重量比で1:1〜10が好ましく、その時
のシヨ糖含量1〜10重量%の水性組成物であるこ
とが好ましい。又、三種類の組成物である場合、
例えばシヨ糖(A)/乳糖(B)/イノシトール(B)などの
時には、シヨ糖:乳糖:イノシトール=1:1〜
10:0.001〜1が好ましく、更に好ましくは1:
1〜10:0.01〜0.1で、シヨ糖含量1〜10重量%
の水性組成物である。
この安定化剤に加えられる酵素の割合は、安定
化剤溶液中好ましくは0.1〜5重量%であり、特
に1〜3重量%が好ましい。本発明の酵素とは、
例えばアルコールオキシダーゼ、グルコースオキ
シダーゼ、コレステロールオキシダーゼ、グリセ
ロールオキシダーゼ、キサンチンオキシダーゼ、
アスコルビン酸オキシダーゼ、等のオキシダーゼ
類、カタラーゼ、セルラーゼ、リパーゼ、アミラ
ーゼ、プロテアーゼ、DNAリガーゼ、DNAポリ
メラーゼ、アデノシントリフオスフアターゼ、リ
ボヌクレアーゼ、ラクターゼ、フオスフアター
ゼ、ポリヌクレオチドキナーゼ、β−1,4−グ
ルカナーゼ等が拳げられる。特に本発明の安定化
剤は、アルコールオキシダーゼ、カタラーゼに対
して有用である。凍結乾燥は、例えば安定化剤と
酵素を含む水性組成物を−20〜−80℃で凍結し、
日本真空技術(株)DF−01Gを使用して、0.15Torr
の減圧下、20〜24時間で乾燥される。
本発明により安定化された酵素含有組成物は、
凍結乾燥時の失活は全く認められず、凍結乾燥品
を長期間保存しても、もとの酵素活性が維持され
る。
〔実施例〕
次に本発明の詳細について実施例をもつて説明
する。
以下の実施例ではシヨ糖と乳糖、又はシヨ糖と
乳糖及びイノシトールを添加したアルコールオキ
シダーゼ(AODと称す)及びカタラーゼ(CAT
と称す)を含む液を凍結乾燥し酵素活性の経日変
化を調べた例を示した。ここで用いたアルコール
オキシダーゼ及びカタラーゼはメタノールを唯一
の炭素源として生育するリポマイセス・メタノシ
ルビエンシス(Lipomyces methanosilviensis)
由来の酵素であり、本菌株は既に微生物受託番号
第5489号として昭和55年4月15日付で工業技術院
微生物工業技術研究所へ寄託されており、その菌
学的性質は特公昭57−28551号公報に記載されて
いるとおりである。又、そのAODの性質につい
ては、特願昭58−9868号に記載されたとおりであ
る。
実施例1及び比較例1
(各種安定剤の検討)
前記したリポマイセス・メタノシルビエンシス
より得られたアルコールオキシダーゼ620V、カ
タラーゼ6500V/0.5ml10mMNaPB(PH7)の酵
素溶液に各物質6%及び6%シヨ糖を含む溶液
0.5ml加え凍結乾燥した。37℃1週間放置し残存
活性を測定した。結課を第一表に示した。
[Object of the Invention] The present invention relates to an enzyme stabilizer and an enzyme preservation method. More specifically, the present invention relates to an enzyme stabilizer added to prevent a decrease in enzyme activity and maintain enzyme activity over a long period of time, and a method for preserving enzymes stabilized thereby. The goal is to keep unstable enzymes stable for long periods of time so that they can be used effectively. [Industrial Application Fields] Enzyme-containing compositions are used in many fields as catalysts, such as enzyme reagents, enzymes for clinical analysis, and industrial enzymes for food. However, these enzyme-containing compositions may be deactivated during storage or during freeze-drying, and it is necessary to stabilize the enzyme and prevent its deactivation in industrial fields that use enzymes. . [Prior Art] Conventionally, as stabilizers for enzyme compositions, proteins without enzymatic activity such as bovine serum argumin, human serum argumin, and egg white argumin, and saccharides such as sucrose, glucose, lactose, and water-soluble polysaccharides have been used. , salts such as ammonium sulfate, glycerol, organic solvents, etc. have been used. [Problems to be solved by the invention] Even if the enzyme stabilizer described above is used alone, a satisfactory stabilizing effect cannot be obtained for some enzymes. There were cases where enzyme activity decreased. Particularly regarding alcohol oxidase and catalase, there was a problem in that the enzyme activity significantly decreased during freeze-drying and subsequent stability tests. We conducted research on stabilizers that can keep the activities of these two types of enzymes as stable as possible, leading to the present invention. [Means for Solving the Problem] Therefore, the present inventors conducted extensive research on stabilizers that can keep the activities of these two enzymes as stable as possible even after freeze-drying, and found that they We have completed the present invention by discovering that a specific combination of enzyme stabilizers dramatically improves stability compared to when conventional stabilizers are used alone. That is, the present invention provides an enzyme stabilizer comprising two or more types of sucrose (A) and a compound (B) selected from the group consisting of lactose, inositol, sorbose, asparagine, and threonine, and this stabilizer. The present invention provides a method for preserving an enzyme, which comprises freeze-drying a composition comprising the enzyme and the enzyme. The enzyme stabilizer of the present invention is preferably a combination of sucrose and lactose, sucrose and lactose and inositol, sucrose and threonine, sucrose and sorbose, sucrose and asparagine, sucrose and inositol,
In particular, combinations of sucrose, lactose, and sucrose, lactose, and inositol are preferred. The mixing ratio of these sucrose (A) and the selected compound (B) is preferably 1:1 to 10 by weight, and the aqueous composition preferably has a sucrose content of 1 to 10% by weight. . In addition, in the case of three types of compositions,
For example, in the case of sucrose (A) / lactose (B) / inositol (B), sucrose: lactose: inositol = 1:1 ~
10: is preferably 0.001 to 1, more preferably 1:
1-10: 0.01-0.1, sucrose content 1-10% by weight
It is an aqueous composition of. The proportion of enzyme added to the stabilizer is preferably 0.1 to 5% by weight, particularly preferably 1 to 3% by weight in the stabilizer solution. The enzyme of the present invention is
For example, alcohol oxidase, glucose oxidase, cholesterol oxidase, glycerol oxidase, xanthine oxidase,
Oxidases such as ascorbate oxidase, catalase, cellulase, lipase, amylase, protease, DNA ligase, DNA polymerase, adenosine triphosphatase, ribonuclease, lactase, phosphatase, polynucleotide kinase, β-1,4-glucanase, etc. I get punched. In particular, the stabilizer of the present invention is useful against alcohol oxidase and catalase. Freeze-drying involves, for example, freezing an aqueous composition containing a stabilizer and an enzyme at -20 to -80°C;
0.15 Torr using Japan Vacuum Technology Co., Ltd. DF-01G
Dry under reduced pressure for 20 to 24 hours. The enzyme-containing composition stabilized according to the present invention comprises:
No deactivation was observed during freeze-drying, and the original enzyme activity was maintained even if the freeze-dried product was stored for a long period of time. [Example] Next, the details of the present invention will be explained using an example. In the following examples, alcohol oxidase (referred to as AOD) and catalase (CAT) containing sucrose and lactose, or sucrose and lactose, and inositol were added.
An example of freeze-drying a solution containing 30% of enzymes and examining changes in enzyme activity over time is shown. The alcohol oxidase and catalase used here are derived from Lipomyces methanosilviensis, which grows using methanol as the sole carbon source.
This strain has already been deposited with the National Institute of Microbial Technology, Agency of Industrial Science and Technology under Microbial Accession No. 5489 on April 15, 1980, and its mycological properties have been published in the Japanese Patent Publication No. 57-28551. As stated in the publication. Further, the properties of the AOD are as described in Japanese Patent Application No. 1983-9868. Example 1 and Comparative Example 1 (Study of various stabilizers) Each substance 6% and 6% sucrose were added to the enzyme solution of alcohol oxidase 620V and catalase 6500V/0.5ml 10mM NaPB (PH7) obtained from Lipomyces methanosylviensis described above. solution containing
Added 0.5 ml and lyophilized. The mixture was left at 37°C for one week and the residual activity was measured. The conclusion is shown in Table 1.
【表】
上表より、シヨ糖とトレオニン、ソルボース、
アスパラギン、イノシトールの各々の併用による
相乗効果が確認された。
実施例2及び比較例2
(アルコールオキシダーゼ及びカタラーゼの安
定化)
前記リポマイセス・メタノシルビエンシスより
部分精製したアルコールオキシダーゼ及びカタラ
ーゼ酵素画分に第二表に示した各種濃度・比率で
シヨ糖及び乳糖を添加し凍結乾燥した。同様にシ
ヨ糖単独のものについても示した。凍結乾燥前の
アルコールオキシダーゼ及びカタラーゼの活性を
各々100%として凍結乾燥直後及び5℃で保存し
た際の活性の変化についての試験結果を第二表に
示した。[Table] From the table above, sugar, threonine, sorbose,
A synergistic effect was confirmed by the combined use of asparagine and inositol. Example 2 and Comparative Example 2 (Stabilization of alcohol oxidase and catalase) Sucrose and lactose were added to the partially purified alcohol oxidase and catalase enzyme fractions from Lipomyces methanosylviensis at various concentrations and ratios shown in Table 2. and freeze-dried. Similarly, sucrose alone is also shown. The activity of alcohol oxidase and catalase before freeze-drying were each set as 100%, and the test results regarding changes in activity immediately after freeze-drying and when stored at 5°C are shown in Table 2.
【表】
上表結果によりアルコールオキシダーゼ及びカ
タラーゼに対するシヨ糖及び乳糖による相乗効果
は顕著であることが確認された。
実施例 3
前記リポマイセスシルビエンシスより部分精製
したアルコールオキシダーゼ及びカタラーゼ酵素
画分に第三表に示した各種濃度、比率でシヨ糖、
乳糖及びイノシトールを加え凍結乾燥した。凍結
乾燥前の酵素活性を100%として凍結乾燥直後及
び5℃で保存した際の活性の変化を第三表に示し
た。[Table] The results in the table above confirm that the synergistic effect of sucrose and lactose on alcohol oxidase and catalase is significant. Example 3 The partially purified alcohol oxidase and catalase enzyme fractions from Lipomyces sylviensis were mixed with sucrose and sucrose at various concentrations and ratios shown in Table 3.
Lactose and inositol were added and freeze-dried. Table 3 shows the change in activity immediately after freeze-drying and when stored at 5°C, assuming that the enzyme activity before freeze-drying is 100%.
【表】
上表結果によりアルコールオキシダーゼ及びカ
タラーゼに対するシヨ糖、乳糖及びイノシトール
の添加効果は顕著であり、微量のイノシトール添
加によりさらに安定性が向上することが確認され
た。
以上の実施例で示したように本発明の酵素安定
化剤により酵素含有組成物の酵素活性は安定に保
持された。[Table] The results in the table above show that the effects of addition of sucrose, lactose, and inositol on alcohol oxidase and catalase are significant, and it was confirmed that the addition of a small amount of inositol further improves stability. As shown in the above Examples, the enzyme activity of the enzyme-containing composition was stably maintained by the enzyme stabilizer of the present invention.
Claims (1)
ス、アスパラギン、トレオニンよりなる群から選
択される化合物(B)との2種以上を含んでなる酵素
の安定化剤。 2 シヨ糖(A)と選択される化合物(B)との重量比が
1:1〜10であり、シヨ糖含量が1.0〜10.0%
(W/V)である特許請求の範囲第1項記載の酵
素の安定化剤。 3 選択される化合物(B)が乳糖及びイノシトール
である特許請求の範囲第1項記載の酵素の安定化
剤。 4 シヨ糖(A)と乳糖、イノシトール、ソルボー
ス、アスパラギン、トレオニンよりなる群から選
択される化合物(B)との2種以上と酵素とからなる
組成物を凍結乾燥してなる酵素保存方法。 5 酵素がアルコールオキシダーゼ及びカタラー
ゼである特許請求の範囲第4項記載の酵素保存方
法。[Scope of Claims] 1. An enzyme stabilizer comprising two or more of sucrose (A) and a compound (B) selected from the group consisting of lactose, inositol, sorbose, asparagine, and threonine. 2 The weight ratio of sucrose (A) and the selected compound (B) is 1:1 to 10, and the sucrose content is 1.0 to 10.0%.
The enzyme stabilizer according to claim 1, which is (W/V). 3. The enzyme stabilizer according to claim 1, wherein the selected compound (B) is lactose and inositol. 4. A method for preserving enzymes, which comprises freeze-drying a composition comprising two or more of sucrose (A) and a compound (B) selected from the group consisting of lactose, inositol, sorbose, asparagine, and threonine, and an enzyme. 5. The enzyme preservation method according to claim 4, wherein the enzymes are alcohol oxidase and catalase.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13650084A JPH0231954B2 (en) | 1984-07-03 | 1984-07-03 | KOSONOANTEIKAZAIOYOBIKOSOHOZONHOHO |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13650084A JPH0231954B2 (en) | 1984-07-03 | 1984-07-03 | KOSONOANTEIKAZAIOYOBIKOSOHOZONHOHO |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6115685A JPS6115685A (en) | 1986-01-23 |
JPH0231954B2 true JPH0231954B2 (en) | 1990-07-17 |
Family
ID=15176615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP13650084A Expired - Lifetime JPH0231954B2 (en) | 1984-07-03 | 1984-07-03 | KOSONOANTEIKAZAIOYOBIKOSOHOZONHOHO |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0231954B2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5185247A (en) * | 1989-03-10 | 1993-02-09 | Miles Inc. | Stabilization of oxidase enzyme-based test strips |
US5116729A (en) * | 1989-03-10 | 1992-05-26 | Miles Inc. | Stabilization of oxidase enzyme-based test strips |
US9481879B2 (en) | 2012-06-26 | 2016-11-01 | Avent, Inc. | Preparation of stabilized catalase enzymes with a surfactant |
US9487759B2 (en) | 2013-02-26 | 2016-11-08 | Avent, Inc. | Preparation of stabilized catalase enzymes using polyvinyl alcohol |
-
1984
- 1984-07-03 JP JP13650084A patent/JPH0231954B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPS6115685A (en) | 1986-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Umbreit et al. | Relation of detergent HLB number to solubilization and stabilization of D-alanine carboxypeptidase from Bacillus subtilis membranes | |
Nozaki | [65] Metapyrocatechase (Pseudomonas) | |
Serrano et al. | Assay of yeast enzymes in situ: a potential tool in regulation studies | |
Hellman et al. | Mast cell content and fatty acid metabolism in the epididymal fat pad of obese mice | |
Ulane et al. | The activating system of chitin synthetase from Saccharomyces cerevisiae. Purification and properties of the activating factor. | |
JP3219181B2 (en) | Stabilization method of cholesterol oxidase | |
US3860484A (en) | Enzyme stabilization | |
WO1992002133A1 (en) | Improved diagnostic and therapeutic compositions | |
Becana et al. | Enzymatic and nonenzymatic mechanisms for ferric leghemoglobin reduction in legume root nodules. | |
Gupta et al. | Phosphoglycerate kinase from young and old Turbatrix aceti | |
Meshalkina et al. | The functional identity of the active centres of transketolase | |
Huisman et al. | Involvement of thiol enzymes in the lysosomal breakdown of native and denatured proteins | |
Kitamura et al. | Purification and characterization of myocardial fructose-6-phosphate, 2-kinase and fructose-2, 6-bisphosphatase. | |
JPH0231954B2 (en) | KOSONOANTEIKAZAIOYOBIKOSOHOZONHOHO | |
Wang et al. | Role of the tetrameric structure of Escherichia coli pyruvate oxidase in enzyme activation and lipid binding | |
Freeze et al. | Carbohydrate composition of human placental N-acetylhexosaminidase A and B | |
Stevens et al. | Hormones and liver cytoplasm. 3. Succinic dehydrogenase, nucleases andpolymerized'ribonucleic acid as affected by hypophysectomy, growth-hormone treatment and adrenalectomy | |
JPH07236483A (en) | Stabilization of physiologically active protein | |
Hicks et al. | Properties of the cyanobacterial coupling factor ATPase from Spirulina platensis: I. Electrophoretic characterization and reconstitution of photophosphorylation | |
Göppinger et al. | Esterase XXVII. Purification and characterization of esterase-9A of mouse kidney | |
EP0065800B1 (en) | Enzyme solutions and method for the preparation thereof | |
US4276376A (en) | Creatine kinase control serum | |
Chandler et al. | Insulin degradation VIII. Protein thiols as co-substrates for glutathione-insulin transhydrogenase | |
Biggs et al. | Studies on the respiratory chain-linked reduced nicotinamide adenine dinucleotide dehydrogenase: XVI. Characteristics of the membrane-bound dehydrogenase in Candida utilis and Saccharomyces cerevisiae | |
Okumura et al. | Role of the carbohydrate moiety of phospholipase B from Penicillium notatum in enzyme activity |